Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Amylx Pharmaceuticals Inc (AMLX) – Amylx Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Amylyx Pharmaceuticals (AMLX) trades at $14.05, down 0.14% on the day, as the stock navigates a pivotal year focused on its lead asset, avexitide. The company reported a net loss of -$144.74M for 2025 and shows negative profitability metrics (ROE: -63.26%), but maintains a strong cash position with $148.80M in net cash flow. Technical indicators are bearish, with an RSI_6 reading of 79.83 signaling overbought conditions, while the overall analyst consensus remains strongly bullish with a $26.50 price target.
The investment thesis hinges on the Phase 3 LUCIDITY trial readout for avexitide expected in Q3 2026, with a potential 2027 launch. While significant cash burn and negative earnings present near-term risks, a successful trial could be transformative. The stark contrast between bearish technicals and overwhelmingly bullish analyst sentiment highlights the binary, event-driven nature of this biotech stock.
Read full analysis

Key Stats

  • Market Cap
    $1.58B
  • Sector
    Health
  • 3M Drawdown
    -30.61%
  • Enterprise Value
    $1.30B
  • Dividend Yield
    -
  • Trading Activity
    84% Buy | 16% Sell
  • Typical Hold Time
    7 days
$14.1
52W Low: $4.9
29 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.58B, with an enterprise value of $1.30B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.9 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -30.61%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 7 days, indicating typical investor behavior on the platform.

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.58B
  • Sector
    Health
  • 3M Drawdown
    -30.61%
  • Enterprise Value
    $1.30B
  • Dividend Yield
    -
  • Trading Activity
    84% Buy | 16% Sell
  • Typical Hold Time
    7 days
$14.1
52W Low: $4.9
29 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.58B, with an enterprise value of $1.30B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.9 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -30.61%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 7 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!